{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:16:46Z","timestamp":1791191806545,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.drugalcdep.2006.09.012","type":"journal-article","created":{"date-parts":[[2006,10,20]],"date-time":"2006-10-20T13:14:34Z","timestamp":1161350074000},"page":"75-78","source":"Crossref","is-referenced-by-count":142,"title":["Abuse liability of buprenorphine\u2013naloxone tablets in untreated IV drug users"],"prefix":"10.1016","volume":"88","author":[{"given":"Hannu","family":"Alho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkki","family":"Vuori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Holopainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2006.09.012_bib1","unstructured":"EMCDDA, 2004. National Prevalence Estimates of Problem Drug Use in the European Union, 1995\u20132000, EMCDDA Project CT.00.RTX.23\u2014Final Report, vol. II\u2014Country Reports. http:\/\/www.emcdda.eu.int\/index.cfm?fuseaction=public.Content&nNodeID=400&sLanguageISO=EN."},{"key":"10.1016\/j.drugalcdep.2006.09.012_bib2","series-title":"Welfare in Finland","first-page":"181","article-title":"Conflicting drug policy\u2014normalization of the drug problem in Finland.","author":"Hakkarainen","year":"2004"},{"key":"10.1016\/j.drugalcdep.2006.09.012_bib3","series-title":"Discussing drugs and control policy. Comparative studies on four Nordic countries","author":"Hakkarainen","year":"1996"},{"key":"10.1016\/j.drugalcdep.2006.09.012_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1360-0443.2004.00958.x","article-title":"Buprenorphine diversion and injecting in Melbourne, Australia: an emerging issue?","volume":"100","author":"Jenkinson","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2006.09.012_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1360-0443.2001.96226710.x","article-title":"Injecting misuse of buprenorphine among French drug users","volume":"96","author":"Obadia","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2006.09.012_bib6","doi-asserted-by":"crossref","unstructured":"Partanen, A., M\u00e4ki, J., 2004. Buprenorphine more common as a problem drug in Finland, Nordic Studies on Alcohol and Drugs. Nordisk Alkohol- & Narkotikatidskrift (NAT), English Supplement, 156\u2013161.","DOI":"10.1177\/145507250402101s17"},{"issue":"6","key":"10.1016\/j.drugalcdep.2006.09.012_bib7","first-page":"534","article-title":"Amfetamiinien ja opiaattien k\u00e4yt\u00f6n yleisyys Suomessa 1998 [The prevalence of amphetamine and opiate users in Finland 1998]","volume":"65","author":"Partanen","year":"2000","journal-title":"Yhteiskuntapolitiikka"},{"key":"10.1016\/j.drugalcdep.2006.09.012_bib8","first-page":"3605","article-title":"Piikkihuumeiden k\u00e4ytt\u00e4j\u00e4t Riski-tutkimuksessa\u2014buprenorfiinin pist\u00e4minen yleistynyt huumeiden sekak\u00e4yt\u00f6ss\u00e4 [Drug injecting users in Riski Study\u2014increased injecting of buprenorphine]","volume":"39","author":"Partanen","year":"2004","journal-title":"Suomen L\u00e4\u00e4k\u00e4rilehti"},{"key":"10.1016\/j.drugalcdep.2006.09.012_bib9","first-page":"278","article-title":"Amfetamiinien ja opiaattien ongelmak\u00e4yt\u00f6n yleisyys Suomessa 2002 [Prevalence of amphetamine and opiate misuse in Finland 2002]","volume":"69","author":"Partanen","year":"2004","journal-title":"Yhteiskuntapolitiikka"},{"key":"10.1016\/j.drugalcdep.2006.09.012_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1360-0443.1989.tb00589.x","article-title":"Buprenorphine and temazepam abuse by drug takers in Glasgow\u2014an increase","volume":"84","author":"Sakol","year":"1989","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.drugalcdep.2006.09.012_bib11","article-title":"Fatal poisoning in Nordic drug addicts in 2002","volume":"7","author":"Steentoft","year":"2005","journal-title":"Forensic Sci. int."},{"issue":"8457","key":"10.1016\/j.drugalcdep.2006.09.012_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(85)92961-7","article-title":"Abuse of buprenorphine","volume":"28","author":"Strang","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2006.09.012_bib13","unstructured":"United Nations Office on Drugs and Crime, World Drug Report, 2005, vol. 2. http:\/\/www.unodc.org\/pdf\/WDR_2005\/volume_2_chap7_opiates.pdf."},{"key":"10.1016\/j.drugalcdep.2006.09.012_bib14","unstructured":"Virtanen, A., Salaspuro, M., Partanen, A., Kaukonen, O., Kinnunen, A., 2005. National Report to the EMCDDA by the Finnish National Focal Point\u2014Drugs in Finland. http:\/\/ar2005.emcdda.eu.int\/en\/home-en.html."},{"key":"10.1016\/j.drugalcdep.2006.09.012_bib15","first-page":"3403","article-title":"Fatal poisonings in Finland during 2000 and 2001 based on forensic toxicological investigations","volume":"35","author":"Vuori","year":"2003","journal-title":"Suomen L\u00e4\u00e4k\u00e4rilehti"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871606003449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871606003449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T23:15:05Z","timestamp":1555888505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871606003449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0376871606003449"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.09.012","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}